CClinicalTrials.gg
Status unknownNCT01153191Updated Nov 4, 2011

Effectiveness for Interventions to Minimize Surgical Site Infections

An interventional study of Normal saline pressurized irrigation and sub-q gentamicin in Infections, sponsored by Dallas VA Medical Center. Status unknown at 1 site in United States. Open to participants aged 18 Years to 95 Years. Per ClinicalTrials.gov, last updated 2011-11-04.

Sponsored by Dallas VA Medical Center · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Nov 2011), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 95 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate two different simple and inexpensive extra treatments during colorectal surgeries to see if this will reduce the rate of post operative infections

Read the detailed description

The population for inclusion for this study will be drawn from the patients undergoing elective transabdominal colorectal surgery. This population was chosen due to its inherently high rate of superficial-incisional infection.Colorectal procedures stand out as a particularly highrisk surgery with respect to SSI. Several studies have reported rates of infection of 25% or more making colorectal surgeries an excellent opportunity for testing new strategies to reduce SSI.

This pilot project seeks to preliminarily evaluate two new strategies that are inexpensive and could be readily incorporated into current practice. The strategies are pressurized irrigation of the superficial surgical wound (above the fascia) and subcutaneous injection of gentamicin into the surgical wound prior to initial skin incision. Comparison will be made between prospectively enrolled patients and historic controls.The hypothesis to be tested is that these interventions will significantly reduce superficial incisional infection rates compared with historic control.

02

Conditions studied

  • Infections

Keywords

  • colorectal surgery
03

In context

Infections

6,687 studies on the registry are indexed under Infections; 807 are open to participants now.

This study's planned enrollment of 120 is close to the median of 120 across 4,200 interventional studies indexed under Infections.

Browse Infections studies →

Lead sponsor

Dallas VA Medical Center is the lead sponsor of 28 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 95 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • VA patients getting transabdominal,elective colorectal procedures
  • willing and capable of giving self informed consent

Exclusion criteria

Exclusion Criteria:

  • patients unable to give informed consent
  • emergency colorectal procedures
  • transanal procedures
  • patients who have contaminated or dirty wounds that would preclude attempts at skin closure at the conclusion of the procedure
  • patients undergoing appendectomy
  • patients undergoing intraabdominal procedures not including surgical resection of the colon or rectum (ie.procedures involving small bowel , stomach)
  • patients with pre/op creatinine clearance less than 20ml/min
  • patients with known allergy or hypersensitivity to gentamicin
  • patients that have received gentamicin within 2 weeks of potential study date
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Pressurized irrigation

    first group-After closure of patients abdominal wall fascia, Hydrostatic irrigation with 3 liters of normal saline with Simpulse Solo irrigation system (Davol) at less than 15PSI will be applied to subcutaneous tissues prior to closure

    Procedure: Normal saline pressurized irrigation

  • Experimental
    Sub Q Antibiotic

    second group of patients will receive 2mg/lg of gentamicin in 20 ml of sterile saline injected into the superficial tissues above the ABD wall fascia prior to initial incision

    Drug: sub-q gentamicin

Interventions

  • ProcedureNormal saline pressurized irrigation

    same

    Also known as: 1st group

  • Drugsub-q gentamicin

    2mg/kg of gentamicin in 20 ml of sterile saline up to max dose of 120mg injected above the abdominal wall fascia- the length of the incision will be marked and injection made with intent being to evenly distribute the volume of injection in the subcutaneous tissues in immediate vicinity of and prior to the initial incision- analogous to the technique employed when using local anesthetic

    Also known as: 2nd group

06

What researchers measure

Primary outcomes

  1. Infection rate in colorectal surgeries in each of two treatment arms as compared to historic controls

    pilot study to evaluate 1. pressurized irrigation of the superficial surgical wound after fascial closure in 40 patients and 2. subcutaneous gentamicin into the surgical area prior to initial incision in 40 patients and compare rates of surgical site infections after 30 days to historic controls.

    Time frame: 30 days after surgery

07

Study locations

1 site
  • VANTXHCS
    Dallas, Texas 75216, United States
08

References and documents

Publications

  • Dineen SP, Pham TH, Murray BW, Parker BJ, Hartless K, Anthony T, Huerta S. Feasibility of subcutaneous gentamicin and pressurized irrigation as adjuvant strategies to reduce surgical site infection in colorectal surgery: results of a pilot study. Am Surg. 2015 Jun;81(6):573-9. PubMed 26031269 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 4, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01153191
Lead sponsor
Dallas VA Medical Center
Responsible party
Thomas Anthony (MD, Dallas VA Medical Center) — Principal investigator
First posted
Jun 30, 2010
Start date
Aug 2010
Primary completion
Sep 2012 (estimated)
Completion
Dec 2012 (estimated)
Last update
Nov 4, 2011

Study contacts

Sean Dineen, MD
principal investigator · VANTXHCS

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion